NOEMA PHARMA
Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using their novel therapies. Noema Pharma was founded in 2019 and is based in Basel-Stadt, Switzerland.
NOEMA PHARMA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.noemapharma.com
Total Employee:
11+
Status:
Active
Total Funding:
54 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Global Site Tag
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Luigi Costa Co-Founder and CEO @ Noema Pharma
Co-Founder and CEO
George Garibaldi CMO & Co-Founder @ Noema Pharma
CMO & Co-Founder
Michael Gutch Chief Financial Officer @ Noema Pharma
Chief Financial Officer
2022-02-01
Sally Nixon Head of Operations @ Noema Pharma
Head of Operations
Renata Lazarova VP Clinical Development, Pediatric Programs @ Noema Pharma
VP Clinical Development, Pediatric Programs
Amine Tahiri VP Clinical Development, Adult Programs @ Noema Pharma
VP Clinical Development, Adult Programs
Simon Roitt VP Clinical Operations @ Noema Pharma
VP Clinical Operations
Smiljana Milosavljevic VP Clinical Development, Behavioral Medicine Programs @ Noema Pharma
VP Clinical Development, Behavioral Medicine Programs
Founder
Investors List
Polaris Partners
Polaris Partners investment in Series A - Noema Pharma
BioMedPartners
BioMedPartners investment in Series A - Noema Pharma
Gilde Healthcare
Gilde Healthcare investment in Series A - Noema Pharma
Invus
Invus investment in Series A - Noema Pharma
Sofinnova Partners
Sofinnova Partners investment in Series A - Noema Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-28 | Noema Pharma Appoints Michael Gutch as Chief Financial Officer |
Official Site Inspections
http://www.noemapharma.com Semrush global rank: 5.08 M Semrush visits lastest month: 1.62 K
- Host name: noemapharma.wpmudev.host
- IP address: 45.76.83.58
- Location: Frankfurt am Main Germany
- Latitude: 50.1103
- Longitude: 8.7147
- Timezone: Europe/Berlin
- Postal: 60314
More informations about "Noema Pharma"
Who We Are | Noema Pharma
Our pipeline contains novel therapies designed to address debilitating CNS mediated conditions in order to improve quality of life and patient outcomes.. We partner with patients, families and caregivers, and healthcare professionals to …See details»
Noema Pharma - Crunchbase Company Profile
Contact Email info@noemapharma.com Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and …See details»
Noema Pharma - LinkedIn
Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research …See details»
Noema Pharma Company Profile 2025: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Noema Pharma. Use the PitchBook Platform to explore the full profile.See details»
Noema Pharma - Craft
Noema Pharma is a biotech company developing therapies to address disabling symptoms in orphan conditions of the brain and nervous system. It aims to develop drugs to treat rare …See details»
Noema Pharma - Products, Competitors, Financials, Employees ...
Noemapharma.com. Overview & Products; Financials; People; Founded Year 2019. Stage Series B - II | Alive. Total Raised $202.29M. Last Raised $30.62M | 20 days ago. Mosaic Score. The …See details»
Noema Pharma AG – Swiss Biotech
Noema Pharma is a clinical-stage biotech company targeting debilitating central nervous systems indications. Our pipeline contains novel therapies designed to address CNS disorders in order …See details»
Noema Pharma — Sofinnova Partners
Noemapharma.com. Antoine Papiernik. Chairman & Managing Partner, Sofinnova Partners. Related News. 18 December, 2024 Noema Pharma appoints Volker Knappertz, M.D., as …See details»
Noema Pharma - VentureRadar
Develops innovative therapeutics targeting neuroscience-based disorders through clinical-stage research and multiple Phase 2 trials. " Noema Pharma is a biotech company developing …See details»
Noema Pharma Appoints Michael Samar as Chief Financial Officer
3 days ago He also serves on the Boards of Unity Biotechnology and OUTbio, a non-profit organization for LGBTQ+ professionals in the biotech and related industries. ... Learn more at …See details»
Noema Pharma - Overview, News & Similar companies - ZoomInfo
Dec 7, 2023 Noema Pharma (www.noemapharma.com) is a Swiss-based company targeting neurological disorders characterized by imbalanced neuronal networks. The company is …See details»
Noema Pharma AG - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Noema Pharma AG of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.See details»
Noema Pharma - VentureRadar
Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and... ... Find out ...See details»
Noema Pharma | EU-Startups
Articles about Noema Pharma: December 13, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (Dec 9 – Dec 13) April 5, 2023 March’s funding …See details»
Noema Pharma raises CHF54 million in Series A financing
Dec 1, 2020 Noema Pharma (www.noemapharma.com) is a Swiss-based company targeting orphan neurological disorders characterized by imbalanced neuronal networks. The company …See details»
Noema Pharma, founded by Sofinnova Partners, raises CHF 103 …
Mar 7, 2023 Noema Pharma (www.noemapharma.com) is a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders characterized by imbalanced …See details»
Noema Pharma
At Noema Pharma, we are committed to improving the lives of people affected by debilitating central nervous system (CNS) disorders. As emerging leaders in the field, we’re looking for …See details»
Noema Pharma Appoints Michael Samar as Chief Financial Officer
3 days ago Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced the appointment of Michael SamarSee details»
Noema Pharma Raises CHF 103 Million (USD 112 Million) in
Mar 7, 2023 Noema Pharma (www.noemapharma.com) is a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders characterized by imbalanced …See details»
Noema Pharma Appoints Michael Samar as Chief Financial Officer
3 days ago Appointment Further Strengthens Leadership Team; Follows Appointment of Volker Knappertz, M.D., as Executive Vice President of Research & DevelopmentBASEL, …See details»